These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25480588)

  • 1. Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement.
    Wang JT; Dong MF; Song GM; Ma ZS; Ma SJ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):902-906. PubMed ID: 25480588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacement.
    Dong MF; Ma ZS; Ma SJ; Chai SD; Tang PZ; Yao DK; Wang LX
    Thromb Res; 2011 Nov; 128(5):e91-4. PubMed ID: 21813162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is long-term warfarin therapy necessary in Chinese patients with atrial fibrillation after bioprosthetic mitral valve replacement and left atrial appendage obliteration?
    Zhang L; Jiang S; Ren C; Gao C
    Heart Surg Forum; 2015 Feb; 18(1):E11-6. PubMed ID: 25881216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
    Gulløv AL; Koefoed BG; Petersen P; Pedersen TS; Andersen ED; Godtfredsen J; Boysen G
    Arch Intern Med; 1998 Jul; 158(14):1513-21. PubMed ID: 9679792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-X aortic valve replacement patients treated with low-dose warfarin and low-dose aspirin.
    Oo AY; Loubani M; Gerdisch MW; Zacharias J; Tsang GM; Perchinsky MJ; Hagberg RC; Joseph M; Sathyamoorthy M
    Eur J Cardiothorac Surg; 2024 May; 65(5):. PubMed ID: 38621698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
    Grzymala-Lubanski B; Svensson PJ; Renlund H; Jeppsson A; Själander A
    Heart; 2017 Feb; 103(3):198-203. PubMed ID: 27590664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
    Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
    Puskas JD; Gerdisch M; Nichols D; Fermin L; Rhenman B; Kapoor D; Copeland J; Quinn R; Hughes GC; Azar H; McGrath M; Wait M; Kong B; Martin T; Douville EC; Meyer S; Ye J; Jamieson WRE; Landvater L; Hagberg R; Trotter T; Armitage J; Askew J; Accola K; Levy P; Duncan D; Yanagawa B; Ely J; Graeve A;
    J Am Coll Cardiol; 2018 Jun; 71(24):2717-2726. PubMed ID: 29903344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement.
    Hassouna A; Allam H; Awad A; Hassaballah F
    Cardiovasc Surg; 2000 Oct; 8(6):491-8. PubMed ID: 10996106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.
    Puskas J; Gerdisch M; Nichols D; Quinn R; Anderson C; Rhenman B; Fermin L; McGrath M; Kong B; Hughes C; Sethi G; Wait M; Martin T; Graeve A;
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1202-1210; discussion 1210-1. PubMed ID: 24512654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating the non-electrical risks of atrial fibrillation.
    Gershlick AH
    Eur Heart J; 1997 May; 18 Suppl C():C19-26. PubMed ID: 9152671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
    Ezekowitz MD; Reilly PA; Nehmiz G; Simmers TA; Nagarakanti R; Parcham-Azad K; Pedersen KE; Lionetti DA; Stangier J; Wallentin L
    Am J Cardiol; 2007 Nov; 100(9):1419-26. PubMed ID: 17950801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
    Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
    J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.